Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
JAMA Network Open
|
June 3, 2026
Practical vs Recent Clinical Trial Use Of Dalbavancin
Sarah A Uhm, Bryan T Alexander, Elizabeth R Lyden, et al.
British Journal of Haematology
|
November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961
Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Nutrients
|
October 14, 2023
Dietary Inflammatory Potential and Bone Outcomes in Midwestern Post-Menopausal Women
Mariah Kay Jackson, Laura D Bilek, Nancy L Waltman, et al.
International Journal of Cancer
|
November 25, 2014
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee
David A Rodeberg, Moody D Wharam, Elizabeth R Lyden, et al.
Journal of Pathology Informatics
|
February 14, 2014
Optimal z-axis scanning parameters for gynecologic cytology specimens
Amber D Donnelly, Maheswari S Mukherjee, Elizabeth R Lyden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Aaron R Weiss, Elizabeth R Lyden, James R Anderson, et al.
The American Journal of Surgical Pathology
|
March 13, 2014
Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group
Erin R Rudzinski, James R Anderson, Elizabeth R Lyden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2019
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group
Leo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani, et al.
Journal of Hospital Medicine
|
September 28, 2018
Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI)
Jason F Shiffermiller, Benjamin J Monson, Chad W Vokoun, et al.
International Journal of Molecular Sciences
|
June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
JAMA Network Open
|
June 3, 2026
Practical vs Recent Clinical Trial Use Of Dalbavancin
Sarah A Uhm, Bryan T Alexander, Elizabeth R Lyden, et al.
British Journal of Haematology
|
November 10, 2009
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961
Marilu Nelson, Sherrie L Perkins, Bhavana J Dave, et al.
Nutrients
|
October 14, 2023
Dietary Inflammatory Potential and Bone Outcomes in Midwestern Post-Menopausal Women
Mariah Kay Jackson, Laura D Bilek, Nancy L Waltman, et al.
International Journal of Cancer
|
November 25, 2014
Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee
David A Rodeberg, Moody D Wharam, Elizabeth R Lyden, et al.
Journal of Pathology Informatics
|
February 14, 2014
Optimal z-axis scanning parameters for gynecologic cytology specimens
Amber D Donnelly, Maheswari S Mukherjee, Elizabeth R Lyden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee
Aaron R Weiss, Elizabeth R Lyden, James R Anderson, et al.
The American Journal of Surgical Pathology
|
March 13, 2014
Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group
Erin R Rudzinski, James R Anderson, Elizabeth R Lyden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 13, 2019
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group
Leo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani, et al.
Journal of Hospital Medicine
|
September 28, 2018
Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI)
Jason F Shiffermiller, Benjamin J Monson, Chad W Vokoun, et al.
International Journal of Molecular Sciences
|
June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Page
of 11